Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
363 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (4)
  • Currently Recruiting (2)
  • (-) Closed (2)

Medical Condition

  • Show all (1567)
  • Addiction (14)
  • Allergy, Asthma, & Immunology (11)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (26)
  • Blood Disorders (37)
  • Bone & Muscle (8)
  • Cancer (639)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Dental (2)
  • Developmental Disorders (2)
  • Diabetes (13)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (11)
  • Eye (8)
  • Gastrointestinal and Digestive Diseases (19)
  • Hair and Skin Disorders (1)
  • Headaches (5)
  • Healthy Volunteers (131)
  • Heart Disease (105)
  • Infectious Disease (37)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (35)
  • Lung Disease (29)
  • Meniere's Disease (1)
  • Neurological Disorders (131)
    • Alzheimer's Disease (30)
    • Brain Tumors (47)
    • Cerebral Palsy (1)
    • Dementia (5)
    • Huntington's Disease (2)
    • Multiple Sclerosis (4)
    • Neuromuscular (8)
    • Neuropathy (11)
    • (-) Parkinson's Disease (1)
  • Nutrition (3)
  • Obesity (2)
  • Obstetrics & Gynecology (40)
  • Pain Management (1)
  • Pediatrics (78)
  • Psychiatric Disorders (57)
  • Rehabilitation (7)
  • Stroke (5)
  • Surgery (7)
  • Transplant (36)
  • Urology (4)
  • Vascular Conditions (9)
    • (-) Ischemia (1)
    • Vasculitis (1)
Displaying 1 - 2 of 2

Parkinson's Disease Genetic Study: FoxBioNet ECV-004

Condition: Neurological Disorders / Parkinson's Disease
Investigator: Julian Agin-Liebes, MD
Status: Closed
FoxBioNet ECV-004 is an observational study sponsored by the Michael J. Fox Foundation for Parkinson's Research. The purpose of this study is to investigate a gene called LRRK2. Mutations in the LRRK2 gene are associated with Parkinson's disease (PD), and mutation carriers have greater LRRK2 protein activity. The goal of this study is to identify…
Read More

Study of ESPRIT BTK System for Treatment of Critical Limb Ischemia

Condition: Vascular Conditions / Ischemia
Investigator: Sahil Parikh, MD
Status: Closed
The objective of the LIFE-BTK RCT is to evaluate the safety and efficacy of the ESPRIT BTK device (which is a bioresorbable polymeric scaffold with the everolimus drug and a bioresorbable polymeric coating mounted on a balloon dilatation catheter) compared to Percutaneous Transluminal Angioplasty (PTA), which is is a procedure that can open up a blocked…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science